{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:26:43Z","timestamp":1772843203392,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.ijcard.2003.12.023","type":"journal-article","created":{"date-parts":[[2004,4,3]],"date-time":"2004-04-03T05:19:28Z","timestamp":1080969568000},"page":"91-95","source":"Crossref","is-referenced-by-count":56,"title":["Efficacy and optimal dose of sildenafil in primary pulmonary hypertension"],"prefix":"10.1016","volume":"99","author":[{"given":"Anand","family":"Chockalingam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gnanavelu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Elangovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Jagannathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Alagesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smrita","family":"Dorairajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2003.12.023_BIB1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0272-5231(05)70289-6","article-title":"Medical therapy of pulmonary hypertension. The prostacyclins","volume":"22","author":"Galie","year":"2001","journal-title":"Clin. Chest. Med."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0272-5231(05)70293-8","article-title":"Lung transplantation for primary pulmonary hypertension","volume":"22","author":"Trulock","year":"2001","journal-title":"Clin. Chest. Med."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB4","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0735-1097(02)01786-2","article-title":"Effect of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial","volume":"39","author":"Galie","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/heart.87.4.340","article-title":"Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary thromboembolic pulmonary hypertension","volume":"87","author":"Nagaya","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2003.12.023_BIB6","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/hc3601.096826","article-title":"Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension","volume":"104","author":"Wilkens","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2003.12.023_BIB7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double blind randomized controlled trial","volume":"165","author":"Simmoneau","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB8","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM200011023431814","article-title":"Sildenafil in primary pulmonary hypertension","volume":"343","author":"Prasad","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00000542-199907000-00041","article-title":"Sildenafil ameliorates effects of inhaled nitric oxide withdrawal","volume":"91","author":"Atz","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ijcard.2003.12.023_BIB10","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1136\/heart.84.2.e4","article-title":"Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension","volume":"84","author":"Abrams","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2003.12.023_BIB11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-136-7-200204020-00008","article-title":"Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension","volume":"136","author":"Ghofrani","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mcp.2002.123554","article-title":"Sildenafil from primary and secondary pulmonary hypertension","volume":"71","author":"Waternable","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB13","doi-asserted-by":"crossref","unstructured":"E Michelakis, W Tymchak, D Lien, et al. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide, Circulation 2002 21;105(20):2398\u2013403.","DOI":"10.1016\/S1062-1458(02)00907-8"},{"key":"10.1016\/j.ijcard.2003.12.023_BIB14","first-page":"297","article-title":"Sildenafil in the management of primary pulmonary hypertension","volume":"54","author":"Singh","year":"2002","journal-title":"Indian Heart J."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB15","first-page":"410","article-title":"A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension","volume":"54","author":"Sastry","year":"2002","journal-title":"Indian Heart J."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB16","first-page":"55","article-title":"The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension","volume":"55","author":"Bharani","year":"2003","journal-title":"Indian Heart J."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1155\/2003\/612905","article-title":"Sildenafil treatment of primary pulmonary hypertension","volume":"10","author":"Kevin","year":"2003","journal-title":"Can. Respir. J."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB18","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(02)11024-5","article-title":"Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial","volume":"360","author":"Ghofrani","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2003.12.023_BIB19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1191\/0961203303lu324cr","article-title":"Systemic lupus erythematosus-associated pulmonary hypertension: good outcome following sildenafil therapy","volume":"12","author":"Molina","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.ijcard.2003.12.023_BIB20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0750-7658(02)00863-8","article-title":"Use of oral sildenafil (Viagra) in pulmonary hypertension after cardiac pediatric surgery","volume":"22","author":"Laquay","year":"2003","journal-title":"Ann. Fr. Anesth. Reanim."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB21","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200210-1157BC","article-title":"Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension","volume":"167","author":"Ghofrani","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical bases of perceived exertion","volume":"14","author":"Borg","year":"1982","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.ijcard.2003.12.023_BIB23","first-page":"919","article-title":"The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure","volume":"132","author":"Guyatt","year":"1985","journal-title":"CMAJ"},{"key":"10.1016\/j.ijcard.2003.12.023_BIB24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1378\/chest.124.1.247","article-title":"Effects of the dual endothelin receptor antagonist Bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study","volume":"124","author":"Sitbon","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2003.12.023_BIB25","first-page":"404","article-title":"Chronic oral sildenafil therapy in severe pulmonary artery hypertension","volume":"54","author":"Kothari","year":"2002","journal-title":"Indian Heart J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527304001494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527304001494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T02:56:17Z","timestamp":1550112977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527304001494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0167527304001494"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2003.12.023","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}